Condition: Type 1 DiabetesInterventions: Drug: Evolocumab Cartridge; Drug: Atorvastatin Calcium Tablets; Drug: Ezetimibe Tablets; Drug: 18F-FDG; Device: Angiocatheter 20IV; Device: J-Wire; Device: GlycoCheck Glycocalyx Measurement SoftwareSponsors: NYU Langone Health; National Heart, Lung, and Blood Institute (NHLBI)Recruiting ClinicalTrials online
Category: Clinical Trials
Information and news about current clinical trials
Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen
Condition: Diabetes MellitusInterventions: Procedure: Islet Transplantation + Immunosuppression; Biological: Islet cell transplantationSponsors: City of Hope Medical Center; National Institutes of Health (NIH)Active, not recruiting Author:
A Comparative Study of the Effect of Ayurvedic Drugs and Metformin in the Management of Diabetes Mellitus (Type II)
Condition: Diabetes Mellitus, Type 2Interventions: Drug: Chhinnavahni Kashaya Vati along with Agnimantha Kwatha; Drug: Metformin HydrochlorideSponsor: A & U Tibbia College Karol BaghCompleted Author:
PET Imaging of Cyclooxygenase-2 in Multiple Sclerosis
Condition: Multiple SclerosisInterventions: Drug: 11C-MCI; Drug: 11C-PS13Sponsors: National Institute of Mental Health (NIMH); University of MarylandRecruiting Author:
The Effect of an Interactive Web-based Program in the Management of Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Behavioral: YönetebilirimSponsor: Selcuk UniversityRecruiting Author:
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Condition: Multiple SclerosisInterventions: Drug: Pioglitazone; Drug: clemastine fumarate; Drug: Dantrolene; Drug: PirfenidoneSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting Author:
A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis
Condition: Relapsing Multiple SclerosisInterventions: Other: ofatumumab; Other: glatiramer acetate; Other: interferon β1Sponsor: Novartis PharmaceuticalsRecruiting Author:
Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients – an Observational Study
Condition: Multiple SclerosisIntervention: Other: OfatumumabSponsor: Novartis PharmaceuticalsRecruiting Author:
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)Recruiting Author:
Lower Extremities Closed Kinetic Chain Training for People With MS
Condition: Multiple SclerosisIntervention: Combination Product: Telko plus conventional physical therapy (CPT)Sponsor: Anas Radi Hassan AlashramRecruiting Author:
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
Condition: Progressive Multiple SclerosisInterventions: Drug: Placebo; Drug: Masitinib (4.5)Sponsor: AB ScienceRecruiting Author:
Fatigue and Sleep Quality in Multiple Sclerosis Patients
Condition: Multiple SclerosisIntervention: Other: ReikiSponsor: Istanbul Sabahattin Zaim UniversityRecruiting Author: